Freeman Roy Lester Insider Trades

Insider Trading History

Track insider trading activity for Freeman Roy Lester. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
Director
Holding Value $37.6k 22,640 shares
Last Trade
Feb 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$53.2k 22,640 shares
$2.35
$1.66
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
Director
Holding Value $49.8k 30,000 shares
Last Trade
Jan 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$178k 63,439 shares
$2.81
$1.66
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
Director
Holding Value $0 0 shares
Last Trade
Jan 21, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$178k 63,439 shares
$2.81
$1.66
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
Director
Holding Value $572k 344,452 shares
Last Trade
Jan 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.77M 833,290 shares
$3.32
$1.66
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
Director
Holding Value $49.8k 30,000 shares
Last Trade
Jul 16, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$46.2k 30,000 shares
$1.54
$1.66
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
Director
Holding Value $11.1k 6,667 shares
Last Trade
Jun 30, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$24.1k 6,667 shares
$3.61
$1.66
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
Director
Holding Value $66.4k 40,000 shares
Last Trade
Jun 24, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$32.6k 40,000 shares
$0.81
$1.66
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
Director
Holding Value $37.6k 22,677 shares
Last Trade
Jun 25, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$66.2k 22,677 shares
$2.92
$1.66
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
Director
Holding Value $11.3k 6,825 shares
Last Trade
Dec 22, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$1.66
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
Director
Holding Value $0 0 shares
Last Trade
Dec 22, 2020 Sale
No data
No data
$1.66

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up